Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	4.19	68.3	4.28	3.09	0.57
Short-Term Investments	-	4.4	0.02	3.26	1.18
Cash & Short-Term Investments	4.19	72.7	4.3	6.35	1.75
Cash Growth	-94.24%	1589.22%	-32.25%	262.20%	-56.61%
Accounts Receivable	178.34	162.16	129.59	205.51	138.4
Other Receivables	7	5.52	0.79	3.24	0.12
Receivables	326.83	167.68	130.38	208.75	138.52
Inventory	394.55	239.87	153.67	69.94	58.82
Prepaid Expenses	-	1.37	3.14	1.41	0.27
Other Current Assets	19.19	138.42	31.78	60.26	19.9
Total Current Assets	744.77	620.04	323.28	346.71	219.27
Property, Plant & Equipment	258.56	112.26	112.43	65.51	62.05
Long-Term Investments	24.48	34.94	21.36	37.37	7.04
Other Intangible Assets	3.6	4.79	-	-	-
Long-Term Deferred Tax Assets	4.93	3.79	3.12	2.72	1.82
Other Long-Term Assets	167.33	174.69	15	135	-
Total Assets	1,204	950.51	475.2	587.31	290.18

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	89.14	29.3	13.38	98.46	66.22
Accrued Expenses	0.17	5.81	2.68	3.21	1.84
Short-Term Debt	-	-	-	28.69	18.2
Current Portion of Long-Term Debt	162.23	-	4.86	5.62	9.54
Current Income Taxes Payable	15.3	10.24	8.75	5.42	4.48
Other Current Liabilities	6.63	2.86	0.44	10.69	0.32
Total Current Liabilities	273.47	48.21	30.11	152.09	100.59
Long-Term Debt	15.4	19.4	16.82	17.47	25.76
Pension & Post-Retirement Benefits	2.87	2.11	1.2	1.06	-
Other Long-Term Liabilities	-	-	0	0.01	-0
Total Liabilities	291.74	69.72	48.13	170.62	126.35

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	344.49	344.49	175.23	175.23	100.06
Additional Paid-In Capital	-	431.86	177.97	177.97	30.07
Retained Earnings	-	120.07	86.9	66.2	55
Comprehensive Income & Other	567.43	-15.63	-13.02	-2.7	-21.31
Shareholders' Equity	911.92	880.79	427.08	416.69	163.82
Total Liabilities & Equity	1,204	950.51	475.2	587.31	290.18

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	177.63	19.4	21.68	51.77	53.51
Net Cash (Debt)	-173.44	53.31	-17.37	-45.42	-51.75
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.00	0.31	-0.20	-0.76	-1.02
Filing Date Shares Outstanding	189.44	172.24	87.61	87.61	50.03
Total Common Shares Outstanding	189.44	172.24	87.61	87.61	50.03
Working Capital	471.29	571.83	293.18	194.63	118.68
Book Value Per Share	4.81	5.11	4.87	4.76	3.27
Tangible Book Value	908.32	876	427.08	416.69	163.82
Tangible Book Value Per Share	4.79	5.09	4.87	4.76	3.27
Land	-	59.15	59.15	20.21	11.17
Buildings	-	28.94	18.32	18.51	18.51
Machinery	-	77.68	71.23	60.92	59.02
Construction In Progress	-	2.93	9.25	2.62	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error